Search scope:
排序: Display mode:
Integrated management of cardiac failure: the cardiac failure clinic
Daniel LOISANCE
Frontiers of Medicine 2011, Volume 5, Issue 1, Pages 20-25 doi: 10.1007/s11684-011-0106-1
The prevalence of the risk factors and the risk of cardiac failure are both increasing in China.The wide range of clinical presentations of cardiac failure (acute or chronic) and of therapeutic approachesintegration within the same structure of the various experts involved in the diagnosis and the treatment of cardiacIn these centers, collaboration should replace competition between the medical and the surgical cardiac
Keywords: cardiac failure cardiac transplantation mechanical circulatory support
Distinct mononuclear diploid cardiac subpopulation with minimal cell–cell communications persists in
Frontiers of Medicine Pages 939-956 doi: 10.1007/s11684-023-0987-9
Keywords: mononuclear diploid cardiomyocytes cell–cell communication cardiac fibroblast single-cell RNA sequencing cardiac regeneration
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 58-67 doi: 10.1007/s11684-022-0937-y
Keywords: cardiac disease mortality aged population lung transplantation
Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock
Muhammad Furqan,Yamei Chen,Akintunde Akinleye,Judy Sarungbam,Alan Gass,Karen Seiter,Delong Liu
Frontiers of Medicine 2014, Volume 8, Issue 2, Pages 254-258 doi: 10.1007/s11684-014-0319-1
Keywords: mantle cell lymphoma bendamustine cardiogenic shock
ZHANG Jingqun, SUN Honglei, MA Yexin, WANG Daowen
Frontiers of Medicine 2008, Volume 2, Issue 1, Pages 19-24 doi: 10.1007/s11684-008-0005-2
Keywords: therapy Sprague administration cardiac hypertrophy valsartan
Proteins moonlighting in tumor metabolism and epigenetics
Lei Lv, Qunying Lei
Frontiers of Medicine 2021, Volume 15, Issue 3, Pages 383-403 doi: 10.1007/s11684-020-0818-1
Keywords: moonlighting function tumor metabolism epigenetics
Changes in Lipoprotein Lipase in the Heart Following Diabetes Onset Review
Chae Syng Lee, Yajie Zhai, Brian Rodrigues
Engineering 2023, Volume 20, Issue 1, Pages 19-25 doi: 10.1016/j.eng.2022.06.013
Due to its constant pumping and contraction, the heart requires a substantial amount of energy, with fatty acids (FAs) providing a major part of its adenosine triphosphate (ATP). However, the heart is incapable of making this substrate and attains its FAs from multiple sources, including the action of lipoprotein lipase (LPL). LPL is produced in cardiomyocytes and subsequently secreted to its heparan sulfate proteoglycan (HSPG) binding sites on the plasma membrane. To then move LPL to the endothelial cell (EC) lumen, glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) attaches to interstitial LPL and transfers it to the vascular lumen, where the LPL is ready to perform its function of breaking down circulating triglycerides (TG) into FAs. The endo-β-glucuronidase heparanase (Hpa) is unique in that it is the only known mammalian enzyme to cleave heparan sulfate (HS), thereby promoting the abovementioned release of LPL from the cardiomyocyte HSPG. In diabetes, it has been suggested that changes in how the heart generates energy are responsible for the development of diabetic cardiomyopathy (DCM). Following moderate diabetes, with the reduction in glucose utilization, the heart increases its LPL activity at the vascular lumen due to an increase in Hpa action. Although this adaptation might be beneficial to compensate for the underutilization of glucose by the heart, it is toxic over the long term, as harmful lipid metabolite accumulation, along with augmented FA oxidation and thus oxidative stress, leads to cell death. This coincides with the loss of a cardioprotective growth factor—namely, vascular endothelial growth factor B (VEGFB). This review discusses interconnections between Hpa, LPL, and VEGFB and their potential implications in DCM. Given that mechanism-based therapeutic care for DCM is unavailable, understanding the pathology of this cardiomyopathy, along with the contribution of LPL, will help us advance its clinical management.
Keywords: Cardiac metabolism Lipoprotein lipase Heparanase Vascular endothelial growth factor Diabetic cardiomyopathy
Wei Gong,Mengwen Yan,Junxiong Chen,Sandip Chaugai,Chen Chen,Daowen Wang
Frontiers of Medicine 2014, Volume 8, Issue 4, Pages 445-455 doi: 10.1007/s11684-014-0378-3
Keywords: PDE5 cardiac fibrosis TGF-β CREB
Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling
Samuel Chege Gitau,Xuelian Li,Dandan Zhao,Zhenfeng Guo,Haihai Liang,Ming Qian,Lifang Lv,Tianshi Li,Bozhi Xu,Zhiguo Wang,Yong Zhang,Chaoqian Xu,Yanjie Lu,Zhiming Du,Hongli Shan,Baofeng Yang
Frontiers of Medicine 2015, Volume 9, Issue 4, Pages 444-456 doi: 10.1007/s11684-015-0421-z
Keywords: aspirin Akt cardiac hypertrophy GSK-3β Wnt/β-catenin
Vanadium metabolism investigation using substance flow and scenario analysis
Fangfang ZHANG, Huiquan LI, Bo CHEN, Xue GUAN, Yi ZHANG
Frontiers of Environmental Science & Engineering 2014, Volume 8, Issue 2, Pages 256-266 doi: 10.1007/s11783-013-0585-1
Keywords: metabolism vanadium industry substance flow analysis scenario analysis
Insulin resistance and the metabolism of branched-chain amino acids
Jingyi Lu, Guoxiang Xie, Weiping Jia, Wei Jia
Frontiers of Medicine 2013, Volume 7, Issue 1, Pages 53-59 doi: 10.1007/s11684-013-0255-5
Keywords: branched-chain amino acids leucine isoleucine valine insulin resistance
Jingyue Zhang, Yawen Song, Qianqian Shi, Li Fu
Frontiers of Medicine 2021, Volume 15, Issue 5, Pages 649-656 doi: 10.1007/s11684-021-0830-0
Keywords: FASN MGLL lipid metabolism tumor invasion metastasis
PAK1 is a novel cardiac protective signaling molecule
Yunbo Ke,Xin Wang,Xu Yu Jin,R. John Solaro,Ming Lei
Frontiers of Medicine 2014, Volume 8, Issue 4, Pages 399-403 doi: 10.1007/s11684-014-0380-9
We review here the novel cardiac protective effects of the multifunctional enzyme, p21-activated kinasereview, we assemble an overview of the recent findings on PAK1 signaling in the heart, particularly its cardiacWe present a model for PAK1 signaling that provides a mechanism for specifically affecting cardiac cellularWe discuss the anti-adrenergic and antihypertrophic cardiac protective effects of PAK1, as well as its
Keywords: p21-activated kinase 1 (PAK1) heart
Dawen Gao, Xiaolong Wang, Hong Liang, Qihang Wei, Yuan Dou, Longwei Li
Frontiers of Environmental Science & Engineering 2018, Volume 12, Issue 3, doi: 10.1007/s11783-018-1035-x
Keywords: Anammox Metabolism Metagenome Ecological distribution Microbial interactions
Metabolism and immunity in breast cancer
Deyu Zhang, Xiaojie Xu, Qinong Ye
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 178-207 doi: 10.1007/s11684-020-0793-6
Keywords: breast cancer metabolism immunity cancer stem cells
Title Author Date Type Operation
Integrated management of cardiac failure: the cardiac failure clinic
Daniel LOISANCE
Journal Article
Distinct mononuclear diploid cardiac subpopulation with minimal cell–cell communications persists in
Journal Article
Association of cardiac disease with the risk of post-lung transplantation mortality in Chinese recipients
Journal Article
Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock
Muhammad Furqan,Yamei Chen,Akintunde Akinleye,Judy Sarungbam,Alan Gass,Karen Seiter,Delong Liu
Journal Article
Effects of RNA interference targeting angiotensin 1a receptor on blood pressure and cardiac hypertrophy
ZHANG Jingqun, SUN Honglei, MA Yexin, WANG Daowen
Journal Article
Changes in Lipoprotein Lipase in the Heart Following Diabetes Onset
Chae Syng Lee, Yajie Zhai, Brian Rodrigues
Journal Article
Chronic inhibition of cyclic guanosine monophosphate-specific phosphodiesterase 5 prevented cardiac fibrosis
Wei Gong,Mengwen Yan,Junxiong Chen,Sandip Chaugai,Chen Chen,Daowen Wang
Journal Article
Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling
Samuel Chege Gitau,Xuelian Li,Dandan Zhao,Zhenfeng Guo,Haihai Liang,Ming Qian,Lifang Lv,Tianshi Li,Bozhi Xu,Zhiguo Wang,Yong Zhang,Chaoqian Xu,Yanjie Lu,Zhiming Du,Hongli Shan,Baofeng Yang
Journal Article
Vanadium metabolism investigation using substance flow and scenario analysis
Fangfang ZHANG, Huiquan LI, Bo CHEN, Xue GUAN, Yi ZHANG
Journal Article
Insulin resistance and the metabolism of branched-chain amino acids
Jingyi Lu, Guoxiang Xie, Weiping Jia, Wei Jia
Journal Article
Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship
Jingyue Zhang, Yawen Song, Qianqian Shi, Li Fu
Journal Article
PAK1 is a novel cardiac protective signaling molecule
Yunbo Ke,Xin Wang,Xu Yu Jin,R. John Solaro,Ming Lei
Journal Article
Anaerobic ammonia oxidizing bacteria: ecological distribution, metabolism, and microbial interactions
Dawen Gao, Xiaolong Wang, Hong Liang, Qihang Wei, Yuan Dou, Longwei Li
Journal Article